Topics

Light Chain Bioscience Achieves Milestone Payment for Successfully Completing Factor VIII Mimetic Bispecific Antibody Discovery for Takeda

10:08 EST 14 Feb 2020 | Speciality Pharma Journal

Light Chain Bioscience, a company developing bispecific antibodies with a pipeline focused in immuno-oncology, announced that it has achieved a milestone and received a payment under its research and collaboration agreement with Takeda Pharmaceutical Company Limited (Takeda). The milestone was achieved upon the successful completion of the discovery phase and designation by Takeda of undisclosed …

Original Article: Light Chain Bioscience Achieves Milestone Payment for Successfully Completing Factor VIII Mimetic Bispecific Antibody Discovery for Takeda

NEXT ARTICLE

More From BioPortfolio on "Light Chain Bioscience Achieves Milestone Payment for Successfully Completing Factor VIII Mimetic Bispecific Antibody Discovery for Takeda"

Quick Search

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...